What do patients and dermatologists prefer regarding low-risk basal cell carcinoma follow-up care? A discrete choice experiment.
Sven van EgmondEsther de VriesLoes HollesteinMaarten BastiaensKees-Peter de RoosDaniëlle KuijpersEwout Willem SteyerbergMarlies WakkeeKlara MosterdTamar NijstenEsther W de Bekker-GrobPublished in: PloS one (2021)
This discrete choice experiment revealed a feasible strategy to substantially reduce costs, while maintaining quality of care, based on the preferences and needs of BCC patients, which is supported by dermatologists.